Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;186(1):189-191.
doi: 10.1111/bjd.20738. Epub 2021 Oct 19.

A national audit of oral propranolol for the treatment of infantile haemangiomas

C Cotter  1 , L Solman  2 , C Flohr  1
Affiliations

A national audit of oral propranolol for the treatment of infantile haemangiomas

C Cotter et al. Br J Dermatol. 2022 Jan.
No abstract available

PubMed Disclaimer

References

    1. Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011; 28:663-9.
    1. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358:2649-51.
    1. National Institute for Health and Care Excellence. Infantile haemangioma: topical timolol. Available at: https://www.nice.org.uk/advice/esuom47/chapter/full-evidence-summary (last accessed 20 September 2021).
    1. Solman L, Glover M, Beattie PE et al. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. Br J Dermatol 2018; 179:582-9.
    1. Krowchuk DP, Frieden IJ, Mancini AJ et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 2019; 143:e20183475.